通威股份(600438.SH)完成出售通威實業98%股權及100%債權
格隆匯9月30日丨通威股份(600438.SH)公佈,公司於2020年7月14日召開第七屆董事會第九次會議和2020年7月30日召開2020年第二次臨時股東大會審議通過了《關於處置下屬成都通威實業有限公司的議案》。會議決定通過競價方式出售下屬成都通威實業有限公司(以下簡稱“通威實業”)98%股權及公司擁有的通威實業100%債權,交易總金額19.36億元,其中股權交易金額18億元,債權交易金額1.36億元。
截止2020年9月30日,公司已收到交易對方成都宜華置業有限公司支付的交易款19.36億元及資金佔用費820.92萬元,並完成標的股權的過户、工商變更登記及各項資產、資料移交手續。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.